Lexicon Pharmaceuticals Market Cap

Lexicon Pharmaceuticals has a market cap or net worth of $711.78 million as of March 9, 2026. Its market cap has increased by 177.28% in one year.

Market Cap

711.78M

Enterprise Value

671.20M

1-Year Change

177.28%

Ranking

#2774

Market Cap Chart

Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $711.78M, a decrease of -20.11%. That is a compound annual growth rate of -0.86%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	711.80M	70.33%
Dec 31, 2025	417.90M	56.46%
Dec 31, 2024	267.10M	-28.72%
Dec 29, 2023	374.70M	3.94%
Dec 30, 2022	360.50M	-38.54%
Dec 31, 2021	586.60M	45.99%
Dec 31, 2020	401.80M	-8.89%
Dec 31, 2019	441.00M	-37.30%
Dec 31, 2018	703.30M	-32.58%
Dec 29, 2017	1.04B	-27.50%
Dec 30, 2016	1.44B	4.32%
Dec 31, 2015	1.38B	194.45%
Dec 31, 2014	468.40M	-49.30%
Dec 31, 2013	923.80M	-18.41%
Dec 31, 2012	1.13B	159.94%
Dec 30, 2011	435.60M	-10.39%
Dec 31, 2010	486.10M	62.74%
Dec 31, 2009	298.70M	55.98%
Dec 31, 2008	191.50M	-53.80%
Dec 31, 2007	414.50M	50.51%
Dec 29, 2006	275.40M	16.89%
Dec 30, 2005	235.60M	-52.10%
Dec 31, 2004	491.90M	33.02%
Dec 31, 2003	369.80M	49.35%
Dec 31, 2002	247.60M	-58.67%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Gyre Therapeutics	741.67M
Prime Medicine	727.80M
ProKidney	718.99M
Replimune Group	712.60M
Jade Biosciences	711.63M
Theravance Biopharma	709.41M
AgomAb Therapeutics NV	703.27M
Alto Neuroscience	683.15M

Market Cap Rankings